Ameritas Investment Partners’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Hold |
13,004
| – | – | ﹤0.01% | 2811 |
|
|
2025
Q1 | $19K | Hold |
13,004
| – | – | ﹤0.01% | 2581 |
|
|
2024
Q4 | $27.7K | Hold |
13,004
| – | – | ﹤0.01% | 2492 |
|
|
2024
Q3 | $36.4K | Buy |
13,004
+4,900
| +60% | +$13.7K | ﹤0.01% | 2370 |
|
|
2024
Q2 | $18.9K | Hold |
8,104
| – | – | ﹤0.01% | 2642 |
|
|
2024
Q1 | $36.2K | Hold |
8,104
| – | – | ﹤0.01% | 2306 |
|
|
2023
Q4 | $26K | Hold |
8,104
| – | – | ﹤0.01% | 2468 |
|
|
2023
Q3 | $25.7K | Buy |
8,104
+2,067
| +34% | +$6.55K | ﹤0.01% | 2427 |
|
|
2023
Q2 | $30K | Hold |
6,037
| – | – | ﹤0.01% | 2333 |
|
|
2023
Q1 | $29.8K | Hold |
6,037
| – | – | ﹤0.01% | 2276 |
|
|
2022
Q4 | $41.4K | Hold |
6,037
| – | – | ﹤0.01% | 2194 |
|
|
2022
Q3 | $65K | Hold |
6,037
| – | – | ﹤0.01% | 1785 |
|
|
2022
Q2 | $68K | Buy |
6,037
+705
| +13% | +$7.94K | ﹤0.01% | 1777 |
|
|
2022
Q1 | $49K | Hold |
5,332
| – | – | ﹤0.01% | 2064 |
|
|
2021
Q4 | $80K | Hold |
5,332
| – | – | ﹤0.01% | 1815 |
|
|
2021
Q3 | $137K | Hold |
5,332
| – | – | 0.01% | 1493 |
|
|
2021
Q2 | $139K | Buy |
5,332
+738
| +16% | +$19.2K | 0.01% | 1517 |
|
|
2021
Q1 | $162K | Hold |
4,594
| – | – | 0.01% | 1344 |
|
|
2020
Q4 | $116K | Hold |
4,594
| – | – | 0.01% | 1493 |
|
|
2020
Q3 | $173K | Buy |
4,594
+309
| +7% | +$11.6K | 0.01% | 1108 |
|
|
2020
Q2 | $183K | Buy |
4,285
+934
| +28% | +$39.9K | 0.01% | 1059 |
|
|
2020
Q1 | $65K | Hold |
3,351
| – | – | ﹤0.01% | 1518 |
|
|
2019
Q4 | $87K | Hold |
3,351
| – | – | ﹤0.01% | 1595 |
|
|
2019
Q3 | $91K | Hold |
3,351
| – | – | ﹤0.01% | 1527 |
|
|
2019
Q2 | $90K | Buy |
3,351
+1,588
| +90% | +$42.7K | ﹤0.01% | 1560 |
|
|
2019
Q1 | $51K | Hold |
1,763
| – | – | ﹤0.01% | 1866 |
|
|
2018
Q4 | $47K | Buy |
+1,763
| New | +$47K | ﹤0.01% | 1844 |
|